Efficacy and safety of a biosimilar recombinant human growth hormone (r-hGH Cristalia) compared with reference r-hGH in children with growth hormone deficiency (CERES study): A randomized, multicentric, investigator-blind, phase 3 trial-Reference-Cited by-同舟云学术

Efficacy and safety of a biosimilar recombinant human growth hormone (r-hGH Cristalia) compared with reference r-hGH in children with growth hormone deficiency (CERES study): A randomized, multicentric, investigator-blind, phase 3 trial

Published:2019-10 Issue: Volume:48-49 Page:29-35
ISSN:1096-6374
Container-title:Growth Hormone & IGF Research
language:en
Short-container-title:Growth Hormone & IGF Research

Author:

Czepielewski M.A.^ORCID,Garret Q.,Vencio S.A.C.,Rassi N.,Felicio J.S.,Faria M.S.,Senn C.C.P.,Bronstein M.D.,Cerqueira M.J.A.G.,Neves A.C.L.,Sgarbi J.A.,Spinola-Castro A.M.,Cunha M.P.R.,Bandeira F.,Toffoletto O.,Afiune J.,Baradelli R.,Rodrigues D.G.,Scharf M.

Funder

Cristália Produtos Químicos Farmacêuticos Ltda

Publisher

Elsevier BV

Subject

Endocrinology,Endocrinology, Diabetes and Metabolism

Reference26 articles.

1. Genetic causes and treatment of isolated growth hormone deficiency-an update;Alatzoglou;Nat. Rev. Endocrinol.,2010

2. Long-term safety of recombinant human growth hormone in children;Bell;J. Clin. Endocrinol. Metab.,2010

3. Guidelines for Growth Hormone and Insulin-Like Growth Factor-I Treatment in Children and Adolescents: Growth Hormone Deficiency, Idiopathic Short Stature, and Primary Insulin-Like Growth Factor-I Deficiency

4. Annex to guideline on similar biological medicinal products containing biotechnology-derived proteins as active substance: Non-clinical and clinical issues;European Medicines Agency,2018

5. Similar biological medicinal products containing recombinant human growth hormone: European regulation;Pavlovic;Horm. Res.,2008

Cited by 8 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Long-term efficacy and safety of PEGylated recombinant human growth hormone in treating Chinese children with growth hormone deficiency: a 5-year retrospective study;Journal of Pediatric Endocrinology and Metabolism;2024-08-23

2. Evaluation of the safety and efficacy of biosimilar recombinant growth hormone in children with growth hormone deficiency: non-inferiority, randomized, parallel, multicentric and Phase III trial;Expert Opinion on Drug Safety;2024-05-08

3. Short-term efficacy and safety of a lower dose of polyethylene glycol recombinant human growth hormone in children with growth hormone deficiency: A randomized, dose-comparison study;Frontiers in Pharmacology;2022-08-11

4. Therapeutic potential of a combination of recombinant human growth hormone (r-hGH) and vitamin D in children with idiopathic short stature;Tropical Journal of Pharmaceutical Research;2022-04-28

5. An Introduction to Biosimilars for the Treatment of Retinal Diseases: A Narrative Review;Ophthalmology and Therapy;2022-03-12